• Bluebird Bio and Gritstone Oncology partner on cancer cell therapies pharmaceutical
    August 27, 2018
    US-based biotechnology companies Bluebird Bio and Gritstone Oncology have entered into strategic collaboration for the development of new cancer cell therapies.
  • Gritstone Oncology files for $80M IPO fiercebiotech
    August 24, 2018
    Gritstone Oncology, the immuno-oncology upstart that has pocketed more than $194 million in venture capital, is going public. The Bay Area biotech is looking to raise up to $80 million in its IPO........
PharmaSources Customer Service